| VIATRIS INC. O.N. |
| USA |
| Gesundheit |
| US92556V1061 / A2QAME |
| VIA (Frankfurt) / VTRS (NASDAQ) |
| FRA:VIA, ETR:VIA, VIA:GR, NASDAQ:VTRS |
| S&P500 |
| https://www.viatris.com/ |
|
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongs..
>Volltext.. |
| 16836.11 Mio. EUR |
| 27514.99 Mio. EUR |
| 12797.87 Mio. EUR |
| 3620.26 Mio. EUR |
| -260.45 Mio. EUR |
| -0.23 EUR |
| 12836.88 Mio. EUR |
| 1586.17 Mio. EUR |
| 1905.04 Mio. EUR |
| 0.33 |
| -4.36% |
| 92.67% |
| 0.41 EUR |
| 2.99% |
| 2.94% |
| 22.05.26 - 0.103296004€ 09.03.26 - 0.102972€ >weitere anzeigen... |
| VIATRIS |
| 27.06.26 |
|
||||
|
||||
|
||||
|
||||
|